You are here
Trendlines Group still a 'buy': DBS research
DBS Group Research has maintained its buy rating on The Trendlines Group, despite the Catalist-listed medical (medtech) and agricultural tech (agtech) incubator losing the bid to renew its agtech incubator licence.
It is "not a material loss", DBS analyst Sachin Mittal
- CALL +65 6388 3838
- EMAIL email@example.com